Hiroaki Ishikura

Statistics

Publications

Citations

201

H-Index

Active since

2011

Affiliations

Astellas Pharma (Japan)(Current)

Hiroaki Ishikura is an author at Astellas Pharma (Japan) specializing in rheumatoid arthritis therapy, rheumatoid arthritis pharmacotherapy, and pharmacology.

Publications per year

2011–2015

Publications

Efficacy and safety of the oral Janus kinase inhibitor peficitinib (ASP015K) monotherapy in patients with moderate to severe rheumatoid arthritis in Japan: a 12-week, randomised, double-blind, placebo-controlled phase IIb study

Tsutomu Takeuchi, Yoshiya Tanaka, Manabu Iwasaki et al. · Annals of the Rheumatic Diseases · 2015 · 147 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of the monoclonal antibody ASK8007 blocking osteopontin in patients with rheumatoid arthritis: a randomised, placebo controlled, proof-of-concept study

Maria J H Boumans, J. G. A. Houbiers, Patrick Verschueren et al. · Annals of the Rheumatic Diseases · 2011 · 54 citations · Full text

Medicine, Immunology, Pharmacology +17

1–2 of 2